TELIX Pharmaceuticals Ltd
TLX•Health Care•Biotechnology•Last updated: Dec 25
About
TELIX Pharmaceuticals Ltd is a biopharmaceutical company focused on the development and commercialization of diagnostic and therapeutic radiopharmaceuticals. The Company operates primarily in the field of oncology, with a pipeline that includes products for prostate, kidney, and brain cancer. TELIX's main segments include the development of molecularly targeted radiation (MTR) products and imaging agents for cancer diagnosis and treatment.
Share Price Chart
Company Details
- Sector
- Health Care
- Industry
- Biotechnology
- ASX Code
- TLX
Related Shares
Investor Resources
Should you buy TELIX Pharmaceuticals Ltd right now?
While TLX looks interesting right now, our experts have just put together a full report on the ultimate ASX investment portfolio - designed for growth and passive income.
Join the Rask weekly investment newsletter to get the names, right now